Effectiveness and safety of blinatumomab for pediatric B cell acute lymphoblastic leukemia with Loeffler's endocarditis

Ann Hematol. 2024 Apr;103(4):1419-1420. doi: 10.1007/s00277-024-05656-5. Epub 2024 Feb 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Bispecific* / adverse effects
  • Burkitt Lymphoma*
  • Child
  • Humans
  • Hypereosinophilic Syndrome*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / complications
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy

Substances

  • blinatumomab
  • Antibodies, Bispecific